154 related articles for article (PubMed ID: 8386497)
1. In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinoma.
Ciomei M; Pastori W; Pastori A; de Castiglione R; Gozzini L; Corradi F
Anticancer Res; 1993; 13(1):75-9. PubMed ID: 8386497
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
3. Bombesin receptor antagonists. 3. Irreversible alkylating analogues: melphalan derivatives.
de Castiglione R; Gozzini L; Galantino M; Corradi F; Arlandini E; Molinari I; Ciomei M
Farmaco; 1991 Jun; 46(6):743-57. PubMed ID: 1663360
[TBL] [Abstract][Full Text] [Related]
4. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
5. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
7. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
8. Bombesin receptor antagonists. 4. Chloromethylketone and chloroethylnitrosourea derivatives.
Lucietto P; de Castiglione R; Gozzini L
Farmaco; 1991 Oct; 46(10):1111-20. PubMed ID: 1667726
[TBL] [Abstract][Full Text] [Related]
9. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
Mantey S; Frucht H; Coy DH; Jensen RT
Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815
[TBL] [Abstract][Full Text] [Related]
10. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
Kado-Fong H; Malfroy B
J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
[TBL] [Abstract][Full Text] [Related]
11. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation.
El-Bayoumy K; Rose DP; Papanikolaou N; Leszczynska J; Swamy MV; Rao CV
Int J Oncol; 2002 Mar; 20(3):557-61. PubMed ID: 11836568
[TBL] [Abstract][Full Text] [Related]
13. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists.
Davis TP; Crowell S; Taylor J; Clark DL; Coy D; Staley J; Moody TW
Peptides; 1992; 13(2):401-7. PubMed ID: 1329046
[TBL] [Abstract][Full Text] [Related]
14. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
15. Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice.
Kiaris H; Schally AV; Nagy A; Sun B; Armatis P; Szepeshazi K
Br J Cancer; 1999 Nov; 81(6):966-71. PubMed ID: 10576652
[TBL] [Abstract][Full Text] [Related]
16. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
Carney DN; Cuttitta F; Moody TW; Minna JD
Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
[TBL] [Abstract][Full Text] [Related]
17. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
Katsuno T; Pradhan TK; Ryan RR; Mantey SA; Hou W; Donohue PJ; Akeson MA; Spindel ER; Battey JF; Coy DH; Jensen RT
Biochemistry; 1999 Jun; 38(22):7307-20. PubMed ID: 10353842
[TBL] [Abstract][Full Text] [Related]
19. Bombesin receptor antagonists [corrected]. 1. Analogues with deleted, inverted or substituted amino acid residues.
De Castiglione R; Gozzini L; Mena R; Brugnolotti M; Ciomei M; Molinari I; Comoglio PM; Gaudino G
Farmaco; 1990 Dec; 45(12):1251-63. PubMed ID: 1965286
[TBL] [Abstract][Full Text] [Related]
20. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]